Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treatment of type 2 diabetes, metabolic syndrome, myocardial injury and neurodegeneration with humanin and analogs thereof

Treatment of type 2 diabetes, metabolic syndrome, myocardial injury and neurodegeneration with humanin and analogs thereof

US Patent 8309525 · Granted Nov 13, 2012

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

MENTSH analogs as therapeutics for diabetes, obesity, and their associated disea2025
MENTSH analogs as therapeutics for diabetes, obesity, and their associated disea2023
MENTSH analogs as therapeutics for diabetes, obesity, and their associated disea2021
Mitochondrial-derived peptide MOTS3 regulates metabolism and cell survival2019
Mitochondrial-derived peptide MOTS3 regulates metabolism and cell survival2018
Treatment of myocardial injury with humanin analogs2015
Biological markers for longevity and diseases and uses thereof2014
Method of treatment of type-1 diabetes with humanin analogues2014
Small humanin-like peptides2014
Biological markers for longevity and diseases and uses thereof2013
Method of treatment of type-1 diabetes with a humanin analogue2011
Biological markers for longevity and diseases and uses thereof2009